Kodiak Sciences (KOD) Liabilities and Shareholders Equity (2017 - 2026)
Kodiak Sciences' Liabilities and Shareholders Equity was $256.81 million in Q2 2026, unchanged from $256.73 million a year earlier and down 16.1% from the prior quarter.
Kodiak Sciences (KOD) Liabilities and Shareholders Equity (2017 - 2026) Analysis & Trends
At the end of FY2025, Liabilities and Shareholders Equity at Kodiak Sciences came in at $351.53 million, up 4.8% from FY2024.
- Liabilities and Shareholders Equity shows a five-year compound annual growth rate of -19.9% (FY2020 to FY2025).
- In earlier years, Liabilities and Shareholders Equity was $335.58 million in FY2024 (-30.0%), $479.37 million in FY2023 (-28.1%), $666.63 million in FY2022 (-26.3%) and $904.22 million in FY2021 (-15.3%).
- Quarterly Liabilities and Shareholders Equity has moved between $218.07 million (Q3 2025) and $958.21 million (Q3 2021) over five years.
- Compared with a year earlier, Liabilities and Shareholders Equity was higher in two of the last eight quarters, with an average decline of 20.4%.
- The best year-over-year quarter for Liabilities and Shareholders Equity over five years was Q3 2021 (growth of 99.3%); the worst was Q3 2025 (a decline of 41.5%).
- Per Business Quant data, KOD's Liabilities and Shareholders Equity in the three quarters before Q2 2026 was $306.01 million (Q1 2026), $351.53 million (Q4 2025) and $218.07 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Kodiak Sciences | 5.96 Bn | 5.96 Bn | - | 256.81 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 256.81 Mn |
| Mar 31, 2026 | 306.01 Mn |
| Dec 31, 2025 | 351.53 Mn |
| Sep 30, 2025 | 218.07 Mn |
| Jun 30, 2025 | 256.73 Mn |
| Mar 31, 2025 | 297.91 Mn |
| Dec 31, 2024 | 335.58 Mn |
| Sep 30, 2024 | 372.67 Mn |
| Jun 30, 2024 | 401.58 Mn |
| Mar 31, 2024 | 434.76 Mn |
| Dec 31, 2023 | 479.37 Mn |
| Sep 30, 2023 | 547.65 Mn |
| Jun 30, 2023 | 589.66 Mn |
| Mar 31, 2023 | 640.33 Mn |
| Dec 31, 2022 | 666.63 Mn |
| Sep 30, 2022 | 723.99 Mn |
| Jun 30, 2022 | 781.91 Mn |
| Mar 31, 2022 | 850.29 Mn |
| Dec 31, 2021 | 904.22 Mn |
| Sep 30, 2021 | 958.21 Mn |
Kodiak Sciences Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=KOD&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "KOD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=KOD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();